Skip Navigation


NDT Advance Access originally published online on June 2, 2007
Nephrology Dialysis Transplantation 2007 22(9):2476-2484; doi:10.1093/ndt/gfm213
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/9/2476    most recent
gfm213v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Miloradovic, Z.
Right arrow Articles by Markovic-Lipkovski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miloradovic, Z.
Right arrow Articles by Markovic-Lipkovski, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade

Zoran Miloradovic1, Mirjana Jerkic2, Durdica Jovovic1, Nevena Mihailovic-Stanojevic1, Jelica Grujic Milanovic1, Gordana Stosic3 and Jasmina Markovic-Lipkovski4

1Institute for Medical Research, Belgrade, Serbia, 2Hospital for Sick Children, Cancer and Blood Program, Toronto, Canada, 3Clinical Center of Serbia, Institute of Neurology, Belgrade and 4Medical School University of Belgrade, Institute of Pathology, Serbia

Correspondence and offprint requests to: Zoran Miloradovic, Institute for Medical Research, Dr Subotica 4, 11129 Belgrade, PO Box 102, Serbia. Email: zokim{at}imi.bg.ac.yu



  Abstract

Background. Acute renal failure (ARF) is a devastating illness, especially when it occurs in various conditions with impaired nitric oxide (NO) synthesis, such as arterial hypertension, heart failure and some renal diseases. We have directed our investigations to effects of both angiotensin II (AII) and endothelin (ET) receptor blockade associated with mild or strong NO deficiency on haemodynamic, biochemical and morphological parameters in experimental post-ischaemic ARF.

Methods. In this study, we used bosentan (dual, ETA/ETB-receptor antagonist), losartan (non-peptide, competitive antagonist of type I AII receptor), and NG-nitro-L-arginine methyl ester (L-NAME), inhibitor of NO synthesis. Experiments were performed in anaesthetized, adult male Wistar rats. The right kidney was removed and the renal ischaemia was performed by clamping the left renal artery for 45 min. Experimental groups received receptor antagonists (bosentan or losartan) or vehicle (saline) in the femoral vein 20 min before, during and 20 min after the period of ischaemia. L-NAME was given as i.v. bolus before each antagonist infusion. All parameters were measured 24 h after reperfusion.

Results. Our results showed that strong NO blockade overcame effects of both ET and AII receptor blockade in experimental post-ischaemic ARF. In addition, the AII receptor blockade had a harmful effect on this condition, probably due to disturbed autoregulatory renal function. On the other hand, ET and AII receptor blockade in mild NO blockade associated with reperfusion injury, improves the most haemodynamic, biochemical and morphological parameters.

Conclusions. We concluded that experimental post-ischaemic ARF is neither AII nor ET mediated in case of strong NO blockade, but, in more realistic conditions of mild NO deficiency, these peptides represent significant players whose receptor blockade expressed relevant therapeutic potential.

Keywords: acute renal ischaemia; angiotensin; endothelin; L-NAME; rats

Received for publication: 17. 2.06
Accepted in revised form: 19. 3.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.